The stock of GRI Bio Inc (GRI) has seen a 53.40% increase in the past week, with a 192.32% gain in the past month, and a 125.41% flourish in the past quarter. The volatility ratio for the week is 34.18%, and the volatility levels for the past 30 days are at 27.61% for GRI. The simple moving average for the past 20 days is 69.76% for GRI’s stock, with a -80.48% simple moving average for the past 200 days.
Is It Worth Investing in GRI Bio Inc (NASDAQ: GRI) Right Now?
The stock has a 36-month beta value of -2.04. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GRI is 2.92M, and at present, short sellers hold a 7.73% of that float. On November 04, 2024, the average trading volume of GRI was 3.76M shares.
GRI) stock’s latest price update
The stock of GRI Bio Inc (NASDAQ: GRI) has increased by 25.28 when compared to last closing price of 0.88. Despite this, the company has experienced a 53.40% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-10-24 that Proceeds from recent exercise of warrants estimated to extend cash runway into mid Q1 2025, including interim data readout from Phase 2a biomarker study of lead program, GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF)
GRI Trading at 102.71% from the 50-Day Moving Average
After a stumble in the market that brought GRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.18% of loss for the given period.
Volatility was left at 27.61%, however, over the last 30 days, the volatility rate increased by 34.18%, as shares surge +207.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +119.87% upper at present.
During the last 5 trading sessions, GRI rose by +53.40%, which changed the moving average for the period of 200-days by -95.77% in comparison to the 20-day moving average, which settled at $0.6480. In addition, GRI Bio Inc saw -96.86% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRI
Current profitability levels for the company are sitting at:
- -1.6 for the present operating margin
- 1.0 for the gross margin
The net margin for GRI Bio Inc stands at -1.53. The total capital return value is set at -1.79. Equity return is now at value -189.06, with -130.64 for asset returns.
Based on GRI Bio Inc (GRI), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -79.54.
Currently, EBITDA for the company is -11.33 million with net debt to EBITDA at 0.72. When we switch over and look at the enterprise to sales, we see a ratio of -0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.11.
Conclusion
To sum up, GRI Bio Inc (GRI) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
